Senate, House agree on FDA reform; key provisions remain but FDA remains threat to America: Newstarget.com

The U.S. Congress has reached agreement on a House and Senate compromise regarding the recently passed FDA reform legislation that aims to improve the safety of pharmaceuticals. The bill will now move to the White House where it is expected to be signed by the President.

While this new FDA reform bill still lacks crucial safety provisions for U.S. consumers (such as banning direct-to-consumer drug advertisements), it at least kept two key provisions intact that may help prevent drug companies from engaging in the routine deceptions that have propped up industry profits at the expense of public safety: 1) Drug companies will not have immunity to lawsuits brought by consumers harmed by dangerous prescription drugs; and 2) Drug companies will eventually be required to publicly disclose the results of drug trials by publishing them on the internet.

The conclusion of this article appears on NewsTarget.com, the independent natural health news source for consumers. This article, along with other related articles and uncensored news on important consumer health topics, can be found at:

Senate, House agree on FDA reform; key provisions remain but FDA remains threat to America

http://www.newstarget.com/022048.html

About NewsTarget

Read by over 500,000 unique readers monthly, NewsTarget is a progressive, independent natural health news site that teaches consumers how to improve their health through foods, herbs, exercise and natural therapies. The site also warns consumers about the dangers of processed foods, pharmaceuticals, chemotherapy, environmental toxins and the failure of government regulators like the FDA.